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[571 ABSTRACT 
A method of staining preselected, mounted specimens of 
either biological or nonbiological material enclosed within a 
staining chamber where the liquid staining reagents are 
applied and removed from the staining chamber using 
hypergravity as the propelling force. In the preferred 
embodiment, a spacecraft-operated centrifuge and method 
of diagnosing biological specimens while in orbit, charac- 
terized by hermetically sealing a shell assembly. The assem- 
bly contains slide stain apparatus with computer control 
therefor, the operative effect of which is to overcome 
microgravity, for example on board an International Space 
Station. 
10 Claims, 2 Drawing Sheets 
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STAINING METHOD AND APPARATUS 
RELATED APPLICATIONS 
required large volumes of buffer solutions and had limited 
use due to precipitate formation in the staining solutions 
which blocked the intricate tubing arrangement required to 
apply the staining solutions to the blood smear. A second 
s attempt was based upon an airtight chamber design which 
contained a blood Smear slide, into which buffer solutions 
staining solutions were introduced using a vacuum 
system. System operation relied upon a series of one-way 
and two-way valves in order to achieve an efficient vacuum 
i o  into which the staining solutions were introduced by hypo- 
dermic syringe. The original technology used a hand-held 
squeeze bulb to create the vacuum which proved inadequate. 
A later version incorporated mechanical pumps to provide 
both vacuum production and syringe emptying. The hand- 
IS operated version of this technology, although shown to work 
on the ground and which passed initial testing aboard the 
KC-135 parabolic aircraft, did not fulfill its potential; thus 
this technology has been shelved as a viable solution to slide 
staining on-orbit, not least because of its requirement for 
U.S. Provisional Application Ser. No. 601082,217-filed 
Apr. 17, 1998 entitled Centrifuge-Operated Slide Staining 
Technology (COSST) 
U.S. GOVERNMENT RIGHTS 
This invention was made with Government support under 
contract NCC9-41 awarded by NASA. The Government has 
certain rights in this invention. 
BACKGROUND OF INVENTION 
A differential white cell count (DWCC) is an important 
diagnostic tool which can be used to distinguish between 
various conditions which induce alterations in the total 
number and type of white blood cells produced by the 
human body. For example, a DWCC can be used to distin- 2o 
guish between bacterial or viral infections, in the differential 
diagnosis of an allergic reaction or to detect the presence of 
myoproliferative disorders or leukemia on board an Inter- 
crew interaction. 
PRIOR ART 
national Space Station, ISS. - -  INVENTOR D H E  PAT. NO. DESCRIPTION 
23 
1978 4,069,968 Disposable Tubing Harness Microgravity exposure during space flight results in 
hemodynamic changes in crew members, which in turn 
Herman, 
Persidskv et al. 1981 4,268,393 Apparatus for Centrifugal .. 
impacts upon the production of white blood cells. No data is 
presently available to establish the “normal baseline” for 
white blood cell production in microgravity. Without first 3o Muller 
knowing the extent to which microgravity exposure impacts H~~~~ 1996 5,589,400 Distributing Material onto a 
white blood cell production, or secondly the proper “micro- 
Separation 
Latham, Jr. 
Eberle 1986 4,612,873 Centrifuge Chamber 
1981 
1993 5,260,032 Integral Centrifuge Tube 
4,285,464 Apparatus for Separation of Blood 
Microscope 
gravity baseline” for a normal healthy crew-member in 
space, it is quite possible that a bacterial or viral infection 
may be overlooked or misdiagnosed, or that a potentially 35 SUMMARY OF INVENTION 
attributed to a bacterial or viral infection in a particular of a standard glass or plastic m~croscope specimen slide or 
a filter whereby biological cells contained in a blood sample crew-member. 
At the Present time it is impossible to Perform DWCC or tissue culture medium sample can be separated from the 
while aboard an orbiting space craft. Whole blood Smears 40 fluid portion of the sample. Specimens, trapped on or in such 
have been Produced in microgravity, but as Yet it has a filter, may be stained as herein defined, the filter being 
remained impossible to perform DWCC without returning configured in the form of a standard specimen slide, 
the blood smear to Earth. Due to the limited life span of such microgravity, one of the major cohesive forces respon- 
smears it is impossible to make a definitive statement with sible for the physical properties of a liquid on earth, namely 
blood cell profile based on such samples. Until real-time object, including a liquid, continues to have but not 
aboard the space craft, critical crew health information differently in microgravity than in normal gravity, one 
remains unobtainable. specific example of reducing the surface tension of a liquid 
In a terrestrial setting, a differential white cell count is 50 in microgravity is that if a volume of liquid is introduced 
obtained by firstly Preparing a blood Smear on a glass slide, into a confined volume of space, such as a test-tube, it will 
fixing the cells in the Smear to the surface of the slide, form much larger droplets than it does in terrestrial gravity. 
staining the cells with a histochemical stain followed by In combination with this effect and the lack of weight the 
washing the slide in a clean buffer solution prior to viewing liquid exhibits in microgravity, the liquid will not form a 
under the microscope where a differential white blood cell 5s discrete column of liquid in the bottom of the test-tube as it 
count is made by morphological criteria. The Protocol would on Earth, but rather a mixture of air and water 
outlined above is a simple and universally used technique to dispersed throughout the volume of the test-tube, This has, 
Perform a DWCC. However, this technique requires the use and continues to be, a recurring problem with regard to 
of liquid buffer solutions, including fixatives and dye soh-  liquid handling in microgravity, Staining of biological speci- 
tions. While this technique is performed easily on Earth, the 60 mens on Earth is achieved by placing the specimen in 
problems associated with liquid handling in microgravity containers full of liquid staining solutions, Due to the 
make such a task practically impossible. problems associated with liquid handling in microgravity 
Past attempts at solving this problem have induded sev- this approach to staining biological specimens in space has 
era1 cell stainers which were tested by NASA or its con- to date met with little success. The invention described 
tractor personnel but have since proved unsuitable for use in 65 herein thus achieves staining of slide-mounted specimens 
microgravity. The first attempt was a slide stainer which flew using liquid reagents during space flight by removing the 
aboard Sky Lab. This device proved very cumbersome, source of the problems associated with liquid handling in 
much more serious problem, such as leukemia, may be The term “slide” as used herein encompasses employment 
regard to the effect of microgravity exposure upon white 45 surface tension, is reduced. In addition, by definition an 
Performance and analysis of a DWCC can be achieved weight in zero gravity. As a consequence, liquids behave 
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space, namely microgravity. This is achieved by incorporat- 
ing a device which operates inside the standard laboratory 
centrifuge, manifested for flight on the International Space 
Station. This device, termed the Centrifuge-Operated Slide 
Staining or COSS unit, operates inside the on-board spin- 
ning centrifuge, thus negating any problems associated with 
liquid handling due to lack of gravity. The COSS unit 
operates within a sealed shell. All buffersistaining solutions 
are contained in disposable cartridges which are sequentially 
emptied by the centrifugal force produced within the spin- 
ning centrifuge when a retaining pin is removed from the 
weighted plunger assembly. Air displaced from the staining 
chamber is vented to the space previously occupied by the 
cartridge plunger. Staining solution or buffer is expelled 
from the staining chamber by activation of a one-way valve 
at the base of the staining chamber into a disposable waste 
container situated at the base of the COSS unit. Again, 
displaced air is vented back to the staining chamber. The 
one-way valve to the waste chamber is then closed and the 
staining chamber is then again filled with the appropriate 
bufferistaining solution. Air venting during operation of the 
COSS unit within the centrifuge is achieved by a gravity- 
operated ring seal valve which is open at more than l x g  but 
closes upon return to microgravity after the centrifuge stops 
spinning. 
DESCRIPTION OF THE DRAWINGS 
In each of FIGS. 1 and 3 the symbol Z,1 represents liquid 
movement during centrifugation; the symbol Z,2 represents 
displaced air movement during centrifugation. 
FIG. 1 is a schematic view in vertical section of one form 
of COSS apparatus herein. 
FIG. 2 is a schematic view in horizontal section of the 
present COSS apparatus taken along the line 2-2 of FIG. 
1. 
FIG. 3 is a schematic view in vertical section of a second 
embodiment of the COSS apparatus. 
FIG. 4 is a schematic view in horizontal section of the 
COSS apparatus of FIG. 3 along the line 3-3 thereof. 
DESCRIPTION OF PREFERRED 
EMBODIMENTS 
The COSS apparatus has been created primarily to solve 
a problem raised by the requirement for real-time analysis of 
crew-member blood samples, specifically the requirement 
for a DWCC, preparation of which, on-orbit at the present 
time, is impossible. The device 100 is thus the first slide 
staining device designed to operate with a centrifuge to 
overcome the problems of liquid handling in microgravity. 
The hermetically sealable shell assembly 110 is simple and 
easy to use with minimal crew-member training required. 
The final device is fabricated so that it operates without the 
need for crew-member supervision, except for placing the 
blood smear slide into its staining chamber 120, sealing the 
device, placing it into a sealed on-board centrifuge, not 
shown, and switching on the centrifuge. The device will 
control bufferistaining solution entry to the staining chamber 
and evacuation of the solutions to the waste chamber 140 via 
an integral microprocessor chip, secured in the lid. This 
microprocessor will be programmed to apply and remove 
staining solutions or buffers to blood smear slide 122 after 
requisite fixing, staining or washing times by allowing 
disposable cartridge plungers 132-132', releasable by elec- 
tromechanical means, to descend sequentially, thereby forc- 
ing a buffer solution up into the staining chamber 120. After 
the requisite interval, staining chamber 120 is evacuated 
between applications of required buffer solution by opening 
of one-way valve 124' to the waste chamber 140. As the 
COSS device will operate only in the greater than l x g  
environment produced within the on-board centrifuge, liquid 
5 movement will always be in the direction of the gravity 
vector, i.e. towards the baseiwaste chamber 140 of the 
device. This method and apparatus completely abolishes the 
problems associated with liquid handling in microgravity, 
such as mixing problems, air bubbles remaining in the liquid 
resulting in improper staining, air bubbles becoming trapped 
in tubing or corners of the staining chamber 120 i.e. which 
prevents access and flow of the liquid to the blood smear 
slide 122 and removal of the liquid once it has performed its 
requisite task. In addition, since the present device operates 
1~ as a sealed unit, the risk of escape of staining solutions into 
the crew compartment is minimal, excepting catastrophic 
failure of both the present device and the sealed chamber of 
the centrifuge. 
The COSS device 100 functions using pairs of disposable 
20 cartridges 13&130' which contain the fixing, staining and 
wash buffer solutions required for a DWCC and a disposable 
waste container 140 to store the used staining buffers. See 
FIG. 2. In this configuration, the present device will be 
essentially reusable except for the disposable elements 
2s thereof, namely the buffer cartridges 130-130'slide 120 and 
waste container 140. Due to the use of a hypergravity 
environment, the volumes of buffer and staining solutions 
can be kept to a minimum as the solutions will be applied to 
the slide 120 as an intact sheet of liquid with no air bubbles. 
30 This is ensured due to rising of the liquid level in the staining 
chamber 120 as it is expelled from individual cartridges 
130-130' by respective weighted plunger arms 132-132' of 
the cartridges 130, without mixing with the air in the 
chamber 110. That air is, in turn, vented back via conduits 
35 126 to the space previously occupied by respective cartridge 
plungers 132 through the gravity operated ring seal valves 
124. 
This specific apparatus is important not only for mini- 
mizing waste material aboard the spacecraft, but also for 
40 potential commercial applications in a terrestrial setting. 
These include "hand-free'' preparation of DWCC blood 
smears by non-technical personnel at remote medical facili- 
ties or use of the technology for adaptations such as in situ 
hybridization protocols carried out on tissue sections/ 
45 isolated cell preparations in which extremely small volumes 
of liquid reagents are preferred or obligatory due to the large 
expense or scarcity, respectively, of the reagents. Apreferred 
second embodiment of the COSS device for such an adap- 
tation is illustrated in FIGS. 3 and 4 in which the slide 222 
SO forms one wall of the staining chamber 210. Liquid reagent 
volume can be reduced to a minimum by mounting the 
specimen at the base 224 of the slide 222 and minimizing the 
thickness of the gasket seal 234. Conduit 226 vents air to the 
plunger space. Theoretically, a 10 mm square by 10 microns 
ss thick biological specimen, such as a frozen tissue section, 
mounted on a standard slide placed into the COSS device 
illustrated in FIG. 3, in which the dimensions of the staining 
chamber 220 are 20 mm wide 20 mm high and 20 microns 
thick, delineated by the dimensions of the gasket seal 234 
60 and the volume of liquid introduced into the staining cham- 
ber in a hypergravity environment can be stained using a 
volume of liquid reagent of 7 microliters. In addition, as the 
reagents pass through one-way valve 224' and are collected 
into the waste chamber 240, after being applied to the 
65 specimen in the staining chamber 210, value reagent can be 
reclaimed if required. A third adaptation, in which the COSS 
technology proves useful, are those staining protocols which 
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utilize immunoglobulin staining of tissue sections or single 
cells. These protocols, generically referred to as immu- 
nochemical staining protoco~s, usually require the perme- 
multiple immunoglobulin reagents at specific concentrations 5 
for particular periods of time, interspaced with buffer washes 
and are very sensitive to the sample “drying out,,, The ability 
of the COSS technology to be “pre-programmed” with all of 
the above experimental parameters and to avoid any “drying 
out” of the sample ensures a highly reproducible, 
controllable, automated and hence error-free staining 
method. The present COSS technology thus lends itself to 
using extremely small volumes of reagents due to the 
behavior of liquid at higher than l x g  vectors. By design, the 15 
liquid “stays together as a column or sheet in an enclosed 
space such as the staining chamber 120 of the COSS device, 
per se.” 
One other configuration of the COSS device comprises a 
completely disposable unit except for the reusable micro- 2o 
processor control elements contained in the lid of the device. 
This configuration is employed primarily to reduce crew 
member interaction, such as reloading of disposable car- 
We claim: 
1. A protocol for staining at least one mounted specimen 
of either biological or non-biological substances using com- 
a) physically confining the specimen in a space 
defined as an air containing staining chamber; 
b) forcing at least one liquid staining reagent into an air 
displaceable staining chamber from the base of said 
chamber; 
c) sequentially introducing at least one liquid staining 
reagent into said air displaceable staining chamber 
under hypergravity conditions produced within an 
operating centrifuge, whereby the hypergravity condi- 
tions maintain a highly discrete interface between liq- 
uid and gaseous phases of the specimen within said 
staining chamber by increasing both the relative weight 
and surface tension of the liquid staining solution, 
thereby to prevent mixing of said liquid staining 
reagents with air as they enter the staining chamber and 
to vent air therein. 
2. The protocol of claim 1 wherein the minute volumes of 
differing liquid staining reagents are releaseably contained 
abilization of the sample with detergent, application of paratively Of liquid staining reagents: 
10 
in plural cartridges, not to exceed thirty in number. 
3. The protocol Of wherein the ’pecimen is 
mounted on a standard biological slide prior to introduction tridges. However, due to the envisaged long-term presence 25 in the staining chamber, 
ferred configuration. mounted on a filter, configured as a standard biological 
The toss device may also be produced so that it may specimen slide, prior to introduction of the specimen into the 
staining chamber. contain multiple cartridges containing reagents for staining 5 .  The protocol of claim 3 wherein the surface of the protocols which may be of use in other areas of spacecraft 30 standard biological slide on which the specimen is mounted 
operation. These include a gram stain or calcofluor white defines in part, one side of the staining chamber, 
stain for monitoring bacterial or fungal contamination 6, The protoco~ of claim 4 wherein the surface of the 
respectively of the on-board water or air supply. In addition, standard biological slide on which the specimen is mounted 
biospecimens collected from crew members, including defines in part, one side of the staining chamber, 
blood or urine smears, can be stained for the presence of 35 7. Aprotocol for staining preselected, mounted specimens 
micro-organisms or clinically important cell types utilizing of either biological or non-bio~ogica~ substance in a terres- 
a variety of different histochemical or immunochemical trial or extraterrestrial environmental including: 
staining protocols. Furthermore, tissue sections from experi- a) confining the specimens to be stained; 
mental plants or animals harvested on board the space craft, b) preventing airiliquid staining solution mixing within a 
staining chamber by conducting the staining in a hyper- or isolated cells derived from prokaryotic or eukaryotic 40 tissue cultures grown aboard the space craft can also be gravity environment created within a standard centri- 
stained in a similar fashion for a variety of important 
biological molecules. The COSS device is not limited to 
filters, configured in the shape of a slide, on which single 45 
cells have been trapped or separated from liquid samples. 
The present invention, described in detail in the foregoing 
preferred embodiments and demonstrated in its examples 
thereof, is subject to alterations and modifications by those 50 
skilled in the art. For example, the method and apparatus 
may employ up to thirty cartridges, each containing a 
different liquid reagent, depending upon the staining proto- 
col desired. Such alterations and modifications, inherent in 
the invention, are encompassed within the scope of the 
invention as claimed. * * * * *  
aboard the ISs, cartridge systems are the pre- 4, The protocol of either claim 3 wherein the specimen is 
fuge; 
staining only specimen slides but may also be used to stain introducing to a given ’pecimen at least one comparatively minute volume of a liquid 
reagent. 
8. The protocol of claim 7 wherein the minute volumes of 
differing liquid reagents are releaseably contained in plural 
cartridges, not to exceed thirty in number. 
9. The protocol of claim 8 wherein confining the speci- 
mens is by means of a standard biological specimen slide. 
10. The protocol of claim 9 wherein confining of the 
specimen is by filter means, configured substantially in 
dimensions of a standard biological specimen slide. 
